AP2007004157A0 - N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain - Google Patents

N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain

Info

Publication number: AP2007004157A0
Authority: AP; ARIPO
Prior art keywords: sulfonylaminomethyl; propanecarboxamide; cyclo; pain; treatment
Prior art date: 2005-03-17

Application number

AP2007004157A

Other languages

English (en)

Inventor

Takeshi Hanazawa

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-03-17

Filing date

2006-03-07

Publication date

2007-10-31

2006-03-07 Application filed by Pfizer filed Critical Pfizer

2007-10-31 Publication of AP2007004157A0 publication Critical patent/AP2007004157A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/28—Unsaturated compounds polycyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/16—Unsaturated compounds
- C07C61/40—Unsaturated compounds containing halogen
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hematology (AREA)
Physical Education & Sports Medicine (AREA)
Immunology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Psychology (AREA)
Otolaryngology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Child & Adolescent Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

AP2007004157A 2005-03-17 2006-03-07 N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain AP2007004157A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US66337405P	2005-03-17	2005-03-17
US69980005P	2005-07-15	2005-07-15
US73365105P	2005-11-04	2005-11-04
PCT/IB2006/000557 WO2006097817A1 (en)	2005-03-17	2006-03-07	N- (n-sulfonylaminomethyl) cyclopropanecarboxamide derivatives useful for the treatment of pain

Publications (1)

Publication Number	Publication Date
AP2007004157A0 true AP2007004157A0 (en)	2007-10-31

Family

ID=36570286

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2007004157A AP2007004157A0 (en)	2005-03-17	2006-03-07	N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain

Country Status (25)

Country	Link
US (2)	US7622589B2 (es)
EP (1)	EP1861359B1 (es)
JP (1)	JP4521463B2 (es)
KR (1)	KR100927915B1 (es)
CN (1)	CN101160285A (es)
AP (1)	AP2007004157A0 (es)
AR (1)	AR055878A1 (es)
AU (1)	AU2006224295A1 (es)
BR (1)	BRPI0608436A2 (es)
CA (1)	CA2601508C (es)
CR (1)	CR9375A (es)
DO (1)	DOP2006000063A (es)
EA (1)	EA200701745A1 (es)
GT (1)	GT200600114A (es)
IL (1)	IL185546A0 (es)
MA (1)	MA29335B1 (es)
MX (1)	MX2007011498A (es)
NL (1)	NL1031385C2 (es)
NO (1)	NO20075312L (es)
PE (1)	PE20061150A1 (es)
TN (1)	TNSN07349A1 (es)
TW (1)	TW200716528A (es)
UY (1)	UY29421A1 (es)
WO (1)	WO2006097817A1 (es)
ZA (1)	ZA200707531B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE241351T1 (de)	1996-07-24	2003-06-15	Warner Lambert Co	Isobutylgaba und dessen derivate zur schmerzbehandlung
CN101166524B (zh) *	2005-04-28	2010-12-22	辉瑞有限公司	氨基酸衍生物
WO2007129188A1 (en) *	2006-05-10	2007-11-15	Pfizer Japan Inc.	Cyclopropanecarboxamide compound
CA2658925C (en)	2006-07-27	2015-07-14	Amorepacific Corporation	Novel sulfonylamino acrylamide derivatives, isomer thereof,or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
DK2125797T3 (da)	2007-03-16	2014-02-10	Actelion Pharmaceuticals Ltd	Aminopyridinderivater som s1p1/edg1-receptoragonister
KR101541558B1 (ko)	2007-08-17	2015-08-03	액테리온 파마슈티칼 리미티드	Ｓ1ｐ1/ｅｄｇ1 수용체 조절제로서의 피리딘 유도체
US8153651B2 (en) *	2007-11-13	2012-04-10	Evotec Ag	Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US8557872B2 (en)	2008-01-28	2013-10-15	Amorepacific Corporation	Compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
US11969501B2 (en)	2008-04-21	2024-04-30	Dompé Farmaceutici S.P.A.	Auris formulations for treating otic diseases and conditions
MX2010011545A (es)	2008-04-21	2011-04-11	Otonomy Inc	Formulaciones para tratar enfermedades y afecciones del oido.
KR101621444B1 (ko)	2008-07-02	2016-05-19	(주)아모레퍼시픽	바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염, 및 이를 포함하는 약학 조성물
EP2306975A4 (en)	2008-07-21	2012-10-31	Otonomy Inc	COMPOSITIONS WITH A TAXED RELEASE FOR MODULATING THE EARM STRUCTURE AND THE BORN IMMUNE SYSTEM, AND METHODS OF TREATING EAR OR DISEASE
WO2010056044A2 (ko) *	2008-11-11	2010-05-20	(주)아모레퍼시픽	바닐로이드 수용체 길항제로 작용하는 신규 화합물, 이의 이성질체 또는 이의 약제학적으로 허용 가능한 염 및 이를 포함하는 약학 조성물
KR101252335B1 (ko)	2009-07-16	2013-04-08	(주)아모레퍼시픽	피부 노화 방지용 조성물
KR101367057B1 (ko)	2009-03-17	2014-02-25	(주)아모레퍼시픽	피부 자극 완화용 조성물
CN105254557A (zh)	2009-05-29	2016-01-20	拉夸里亚创药株式会社	作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
US8497271B2 (en) *	2009-10-07	2013-07-30	Bristol-Myers Squibb Company	Modulators of G protein-coupled receptor 88
UA113498C2 (xx)	2010-07-16	2017-02-10		Фосфінові ліганди для каталітичних реакцій
SG10201505540SA (en)	2010-07-16	2015-08-28	Abbott Lab	Process for preparing antiviral compounds
US9255074B2 (en)	2010-07-16	2016-02-09	Abbvie Inc.	Process for preparing antiviral compounds
US8975443B2 (en)	2010-07-16	2015-03-10	Abbvie Inc.	Phosphine ligands for catalytic reactions
US8598213B2 (en)	2011-07-08	2013-12-03	H. Lundbeck A/S	Positive allosteric modulators of nicotinic acetylcholine receptor
UA111746C2 (uk) *	2011-07-08	2016-06-10	Х. Луннбек А/С	Позитивні алостеричні модулятори нікотинового рецептора ацетилхоліну
BR112017001516B1 (pt) *	2015-02-17	2023-10-31	Amorepacific Corporation	Método de ressolubilização quiral, estereoisômero, método para preparar um composto, composto, composição, e kit de ressolubilização quiral
WO2017122754A1 (ja) *	2016-01-12	2017-07-20	日本ケミファ株式会社	電位依存性ｔ型カルシウムチャネル阻害剤
CN109689027A (zh)	2016-06-29	2019-04-26	奥德纳米有限公司	甘油三酯耳用制剂及其用途
KR102599958B1 (ko) *	2016-09-28	2023-11-09	(주)아모레퍼시픽	(r)-n-[4-(1-아미노-에틸)-2,6-다이플루오로-페닐]-메테인설폰아마이드의 제조방법
JP7140332B2 (ja)	2017-01-23	2022-09-21	日本ケミファ株式会社	電位依存性ｔ型カルシウムチャネル阻害剤
JP2023546996A (ja) *	2020-10-23	2023-11-08	ニンバスクロソー，インコーポレイテッド	Ｃｔｐｓ１阻害剤およびその使用
TW202330471A (zh) *	2021-09-30	2023-08-01	日商住友製藥股份有限公司	環丙醯胺衍生物
CN114544845A (zh) *	2022-01-07	2022-05-27	广州白云山医药集团股份有限公司白云山制药总厂	一种盐酸达泊西汀中r异构体的测定方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1108213B (de)	1959-02-28	1961-06-08	Frantisek Sorm Dr Ing	Verfahren zur Herstellung von 2, 2-Dimethyl-3-phenylcyclopropan-carbonsaeuren
NL128365C (es)	1963-11-05
US3526634A (en)	1967-10-30	1970-09-01	Takeda Chemical Industries Ltd	Alkylbenzoylcarbinol esters
US4083336A (en)	1971-08-10	1978-04-11	Texas Instruments Incorporated	Condition responsive control device
JPS565435A (en) *	1979-06-26	1981-01-20	Nissan Chem Ind Ltd	Trans-2,2-dimethyl-3- p-substituted phenyl -cyclopropane- carboxylic acid and its preparation
DE3220730A1 (de) *	1982-06-02	1983-12-08	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung von 2,2-dimethyl-3-aryl-cyclopropan-carbonsaeuren (carbonsaeureestern), neue zwischenprodukte hierfuer und verfahren zu deren herstellung
EP0188887B1 (en)	1985-01-17	1991-05-02	Imperial Chemical Industries Plc	Tertiary amine compounds
US4786646A (en) *	1987-07-10	1988-11-22	Hoffmann-La Roche Inc.	Cyclopropylpropenamides
US4927826A (en) *	1987-07-10	1990-05-22	Hoffman-La Roche Inc.	Cycloproylpropenamides useful as platelet activing factor (PAF) antagonists
DE3815728A1 (de) *	1988-05-07	1989-11-16	Bayer Ag	Stereoisomere von n-(r)-(1-aryl-ethyl)-1-alkyl-2,2-dichlor- cyclopropancarbonsaeureamiden
DE3823521A1 (de)	1988-07-12	1990-02-15	Basf Ag	Cyclopropancarboxamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
DE3824788A1 (de) *	1988-07-21	1990-02-22	Basf Ag	Cyclopropancarboxamide, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von schaedlingen
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5286736A (en) *	1990-11-22	1994-02-15	Dr. Karl Thomae Gmbh	Pyridyl compounds and pharmaceutical compositions containing these compounds
JPH05262698A (ja)	1992-03-24	1993-10-12	Dainippon Ink & Chem Inc	光学活性トリフルオロメチルシクロプロパン誘導体、その合成中間体、それを含む液晶組成物及び液晶表示素子
GB9220137D0 (en)	1992-09-23	1992-11-04	Pfizer Ltd	Therapeutic agents
GB9311282D0 (en)	1993-06-01	1993-07-21	Rhone Poulenc Rorer Ltd	New compositions of matter
ZA961314B (en) *	1995-02-21	1996-08-27	Hoechst Ag	Substituted benzenesulfonylureas and -thioreas processes for their preparation their use for the production of pharmaceutical preparations and medicaments containing them
GB9518953D0 (en)	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
DE19624668A1 (de)	1996-06-20	1998-02-19	Klinge Co Chem Pharm Fab	Verwendung von Pyridylalkan-, Pyridylalken- bzw. Pyridylalkinsäureamiden
DE19624704A1 (de)	1996-06-20	1998-01-08	Klinge Co Chem Pharm Fab	Neue Pyridylalkansäureamide
WO2000035298A1 (en)	1996-11-27	2000-06-22	Wm. Wrigley Jr. Company	Chewing gum containing medicament active agents
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
CN1158264C (zh)	1997-11-21	2004-07-21	Nps药物有限公司	用于治疗中枢神经系统疾病的代谢性谷氨酸受体拮抗剂
DE19756261A1 (de)	1997-12-17	1999-07-01	Klinge Co Chem Pharm Fab	Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide
DE19756235A1 (de)	1997-12-17	1999-07-01	Klinge Co Chem Pharm Fab	Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide
AU760889B2 (en)	1998-10-14	2003-05-22	Ortho-Mcneil Pharmaceutical, Inc.	1,2-disubstituted cyclopropanes
GB9919588D0 (en)	1999-08-18	1999-10-20	Hoechst Schering Agrevo Gmbh	Fungicidal compounds
US20030065176A1 (en)	2000-01-29	2003-04-03	Myung-Gyun Kang	Factor xa inhibitors with aryl-amidines and derivatives, and prodrugs thereof
AU6872401A (en)	2000-06-29	2002-01-14	Abbott Lab	Aryl phenycyclopropyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
DE10036184A1 (de)	2000-07-24	2002-02-14	Aventis Cropscience Gmbh	Substituierte Sulfonylaminomethylbenzoesäure(derivate) und Verfahren zu ihrer Herstellung
DE60133743T2 (de)	2000-08-21	2009-07-02	Pacific Corp.	Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten
ATE328868T1 (de) *	2000-08-21	2006-06-15	Pacific Corp	Neue (thio)harnstoffverbindungen und arzneimittelkompositionen, die diese enthalten
GB0105895D0 (en) *	2001-03-09	2001-04-25	Smithkline Beecham Plc	Novel compounds
CA2449249A1 (en) *	2001-06-12	2002-12-19	Merck & Co., Inc.	Nr2b receptor antagonists for the treatment or prevention of migraines
JP2005528366A (ja)	2002-03-26	2005-09-22	メルク　エンド　カムパニー　インコーポレーテッド	カンナビノイド受容体モジュレータとしてのスピロ環式アミド
US20050004122A1 (en) *	2002-08-14	2005-01-06	Brown Bradley B.	Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use
KR100556158B1 (ko) *	2002-10-17	2006-03-06	(주) 디지탈바이오텍	신규 엔-하이드록시 티오우레아, 우레아 및 아미드계화합물 및 이를 함유하는 약제학적 조성물
EP1565190A4 (en) *	2002-11-22	2006-04-26	Bristol Myers Squibb Co	ARYLCYCLOPROPYLCARBOXYLIC ACID AMIDE AS A KALIUM CHANNEL OPENER
US7148226B2 (en)	2003-02-21	2006-12-12	Agouron Pharmaceuticals, Inc.	Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
EP1628661A2 (en)	2003-06-05	2006-03-01	Vertex Pharmaceuticals Incorporated	Modulators of vr1 receptor
KR100707123B1 (ko) *	2003-07-02	2007-04-16	그뤼넨탈 게엠베하	바닐로이드 수용체의 길항제로서 강력한 진통효과를나타내는 4-(메틸설포닐아미노)페닐 동족체 및 이를함유하는 약학적 조성물
WO2005007614A1 (en) *	2003-07-03	2005-01-27	The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services 6011	Monoamine oxidase inhibitors
US7834013B2 (en)	2003-11-19	2010-11-16	Glaxosmithkline Llc	Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to GPR40
US7244735B2 (en)	2003-12-02	2007-07-17	Vertex Pharmaceuticals Inc.	Heterocyclic protein kinase inhibitors and uses thereof
DE102005011056A1 (de)	2004-03-26	2005-10-13	Merck Patent Gmbh	Fluorcyclopropanderivate
JP2005314407A (ja)	2004-03-31	2005-11-10	Nippon Nohyaku Co Ltd	新規なハロアルキルスルホンアニリド誘導体、除草剤及びその使用方法並びにその中間体
WO2006098554A1 (en)	2005-03-16	2006-09-21	Amorepacific Corporation	Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same

2006
- 2006-03-07 EP EP06710543A patent/EP1861359B1/en active Active
- 2006-03-07 MX MX2007011498A patent/MX2007011498A/es unknown
- 2006-03-07 AP AP2007004157A patent/AP2007004157A0/xx unknown
- 2006-03-07 CN CNA2006800127684A patent/CN101160285A/zh active Pending
- 2006-03-07 WO PCT/IB2006/000557 patent/WO2006097817A1/en not_active Ceased
- 2006-03-07 EA EA200701745A patent/EA200701745A1/ru unknown
- 2006-03-07 CA CA2601508A patent/CA2601508C/en not_active Expired - Fee Related
- 2006-03-07 AU AU2006224295A patent/AU2006224295A1/en not_active Abandoned
- 2006-03-07 JP JP2008501436A patent/JP4521463B2/ja not_active Expired - Fee Related
- 2006-03-07 BR BRPI0608436-2A patent/BRPI0608436A2/pt not_active IP Right Cessation
- 2006-03-07 KR KR1020077021123A patent/KR100927915B1/ko not_active Expired - Fee Related
- 2006-03-15 AR ARP060100987A patent/AR055878A1/es unknown
- 2006-03-15 TW TW095108783A patent/TW200716528A/zh unknown
- 2006-03-15 DO DO2006000063A patent/DOP2006000063A/es unknown
- 2006-03-16 GT GT200600114A patent/GT200600114A/es unknown
- 2006-03-16 NL NL1031385A patent/NL1031385C2/nl not_active IP Right Cessation
- 2006-03-16 UY UY29421A patent/UY29421A1/es not_active Application Discontinuation
- 2006-03-17 PE PE2006000296A patent/PE20061150A1/es not_active Application Discontinuation
- 2006-03-17 US US11/384,127 patent/US7622589B2/en not_active Expired - Fee Related
2007
- 2007-08-27 IL IL185546A patent/IL185546A0/en unknown
- 2007-08-31 ZA ZA200707531A patent/ZA200707531B/xx unknown
- 2007-09-10 CR CR9375A patent/CR9375A/es not_active Application Discontinuation
- 2007-09-14 TN TNP2007000349A patent/TNSN07349A1/fr unknown
- 2007-09-17 MA MA30225A patent/MA29335B1/fr unknown
- 2007-10-17 NO NO20075312A patent/NO20075312L/no not_active Application Discontinuation
2009
- 2009-10-13 US US12/578,061 patent/US7915448B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BRPI0608436A2 (pt)	2009-12-29
EP1861359A1 (en)	2007-12-05
CR9375A (es)	2008-01-29
CA2601508C (en)	2012-01-03
CA2601508A1 (en)	2006-09-21
GT200600114A (es)	2006-10-25
DOP2006000063A (es)	2006-10-15
US20060211741A1 (en)	2006-09-21
IL185546A0 (en)	2008-01-06
MA29335B1 (fr)	2008-03-03
TNSN07349A1 (fr)	2008-12-31
NO20075312L (no)	2007-12-10
US20100035880A1 (en)	2010-02-11
KR100927915B1 (ko)	2009-11-19
WO2006097817A9 (en)	2006-12-07
AU2006224295A1 (en)	2006-09-21
NL1031385C2 (nl)	2007-03-05
EP1861359B1 (en)	2012-11-14
US7915448B2 (en)	2011-03-29
AU2006224295A8 (en)	2009-08-27
MX2007011498A (es)	2007-10-11
ZA200707531B (en)	2008-10-29
PE20061150A1 (es)	2006-11-08
NL1031385A1 (nl)	2006-09-20
EA200701745A1 (ru)	2008-06-30
UY29421A1 (es)	2006-10-31
JP2008535801A (ja)	2008-09-04
KR20070103778A (ko)	2007-10-24
TW200716528A (en)	2007-05-01
CN101160285A (zh)	2008-04-09
JP4521463B2 (ja)	2010-08-11
WO2006097817A1 (en)	2006-09-21
US7622589B2 (en)	2009-11-24
AR055878A1 (es)	2007-09-12

Publication	Publication Date	Title
AP2007004157A0 (en)	2007-10-31	N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
IL201309A0 (en)	2010-05-31	Novel n - (8 - heteroaryltetrahydronaphtalene - 2yl) or n - (5 - heteroarylchromane - 3 - yl) carboxamide derivatives for the treatment of pain
GB0522311D0 (en)	2005-12-07	Pharmaceutical compositions for the treatment of pain
ZA200706791B (en)	2012-01-25	Isoxazole combretasin derivatives for the treatment of disorders
IL208607A0 (en)	2010-12-30	Improved nanobodiestm for the treatment of aggregation-mediated disorders
IL185485A0 (en)	2008-08-07	Use of pde7 inhibitors for the treatment of neuropathic pain
IL191832A0 (en)	2008-12-29	Pyridiazinone derivatives for the treatment of tumours
ZA200706868B (en)	2008-12-31	4-Oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
IL179508A0 (en)	2007-05-15	2-substituted-4- heteroaryl-pyrimidines useful for the treatment of proliferative disorders
SI2024368T1 (sl)	2014-08-29	Derivati 6,7,8,9-tetrahidro-5h-pirimido(4,5-d)azepin-4-il)-amina kot modulatorji trpv 1 za zdravljenje boleäśine
IL177232A0 (en)	2006-12-10	Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IL187715A0 (en)	2008-08-07	Use of phenylsemicarbazones for seed treatment
IL187405A0 (en)	2011-07-31	Methods and compositions for the treatment of pain
IL192933A0 (en)	2009-02-11	Benzoisoindole derivatives for the treatment of pain
PL1907374T3 (pl)	2012-12-31	Pochodne benzylopiperazyny użyteczne do leczenia zaburzeń układu pokarmowego
ZA200707147B (en)	2008-11-26	Use of PDE7 inhibitors for the treatment of neuropathic pain
EP1750698A4 (en)	2010-06-02	5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
PL1959957T3 (pl)	2012-12-31	Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
PL1879585T3 (pl)	2013-08-30	Zastosowanie pochodnych pirymidyloaminobenzamidowych do leczenia mastocytozy układowej
IL178907A0 (en)	2007-03-08	Use of sulglicotide for the treatment of mucositis
ZA200800393B (en)	2009-08-26	Use of phenylsemicarbazones for seed treatment
ZA200710476B (en)	2009-10-28	Methods and compositions for the treatment of pain
ZA200608015B (en)	2008-12-31	Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
HK1141791A (en)	2010-11-19	Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
ZA200806180B (en)	2009-07-29	Benzoisoindole derivatives for the treatment of pain